Alyssa Peterson, PA
Physician Assistant · Brookings, SDNPI 1437743507
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.4% of the total across 190 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,682 and has fallen 57.5% since, to $716 in 2025. Among physician assistant clinicians in SD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 190 payments — averaging $17.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$678
- Teva Pharmaceuticals USA, Inc.$656
- Otsuka America Pharmaceutical, Inc.$634
- Alkermes, Inc.$270
- AbbVie$213
- Tris Pharma Inc$178
- plus $763 from 10 others
What the payments were for
- Food & beverage$3,16893%
- Education$2237%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 44 | $678 |
| Teva Pharmaceuticals USA, Inc. | 20 | $656 |
| Otsuka America Pharmaceutical, Inc. | 41 | $634 |
| Alkermes, Inc. | 15 | $270 |
| AbbVie | 18 | $213 |
| Tris Pharma Inc | 10 | $178 |
| Corium, LLC | 12 | $133 |
| Stryker | 3 | $130 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $102 |
| Neurocrine Biosciences, Inc. | 5 | $83 |
| Vanda Pharmaceuticals Inc. | 2 | $70 |
| Idorsia Pharmaceuticals US Inc | 4 | $54 |
| E.r. Squibb & Sons, L.L.C. | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Merck | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,391 in reported general payments places this provider in the 90th percentile of 548 physician assistant providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 25 | $40,178 |
| BelsomraSuvorexant | 34 | $16,076 |
| Bupropion XlBupropion Hcl | 168 | $2,386 |
| Olanzapine | 69 | $1,590 |
| Hydroxyzine Hcl | 71 | $1,576 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 30 | $1,570 |
| Aripiprazole | 31 | $1,459 |
| Quetiapine Fumarate | 71 | $1,431 |
| Methylphenidate ErMethylphenidate Hcl | 11 | $1,250 |
| Duloxetine Hcl | 109 | $1,064 |
| Escitalopram Oxalate | 92 | $782 |
| Lurasidone Hcl | 11 | $773 |
| Mirtazapine | 78 | $760 |
| Prazosin Hcl | 36 | $755 |
| Clonazepam | 88 | $710 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $213 | $40,17825 claims |
| MerckBelsomra | $17 | $16,07634 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 548 physician assistant providers in South Dakota.
Other physician assistant in Brookings
- Kimberly NelsonSioux Falls$11K
- Jordan HeinsRapid City$10K
- Ryanne WaageAberdeen$9K
- Christina PekoskeSioux Falls$9K
- Rachel HotvetSioux Falls$8K
- Jarrett FowlerRapid City$7K
- Jerome WenningerRapid City$7K
- Alyssa MrsnyDakota Dunes$7K
- Gabriel PenaredondoSioux Falls$7K
- David KingNorth Sioux City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.